Zimmer Biomet Holdings (XSWX:ZBH) Stock Based Compensation: CHF76 Mil (TTM As of Mar. 2026)


XSWX:ZBH Zimmer Biomet Holdings Inc XSWX:ZBH
72 GF Score
Price CHF71.00
GF Value CHF99.84
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings Stock Based Compensation?

Zimmer Biomet Holdings XSWX:ZBH +2.16% 72 Stock Based Compensation is CHF76 Mil as of Mar. 2026. GuruFocus rates XSWX:ZBH with a GF Score™ of 72/100 and a GF Value™ of CHF99.84. The stock has 3 warning signs investors should review.

Zimmer Biomet Holdings's Stock Based Compensation for the three months ended in Mar. 2026 was CHF19 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was CHF76 Mil.

Zimmer Biomet Holdings Stock Based Compensation Related Terms

Zimmer Biomet Holdings Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Zimmer Biomet Holdings's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings Stock Based Compensation Chart

Zimmer Biomet Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.00 97.82 86.31 90.05 71.88

Zimmer Biomet Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.32 17.24 20.14 19.21 19.05
XSWX:ZBH
72GF Score
Zimmer Biomet Holdings Inc XSWX:ZBH
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zimmer Biomet Holdings Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF76 Mil.

What does a Stock Based Compensation of CHF76 Mil mean?
Zimmer Biomet Holdings (XSWX:ZBH) has a Stock Based Compensation of CHF76 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Zimmer Biomet Holdings and its competitors.
Is Zimmer Biomet Holdings' Stock Based Compensation too high?
Zimmer Biomet Holdings' current Stock Based Compensation is CHF76 Mil. Overall, Zimmer Biomet Holdings has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Stock Based Compensation compare to STE and PEN?
Zimmer Biomet Holdings' Stock Based Compensation of CHF76 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current Stock Based Compensation is CHF76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Zimmer Biomet Holdings (XSWX:ZBH) has a current Stock Based Compensation of CHF76 Mil. The stock's GF Value™ is CHF99.84, compared to a current price of CHF71.00 — trading 28.9% below its estimated fair value. The current Stock Based Compensation is CHF76 Mil. Zimmer Biomet Holdings' overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Stock Based Compensation is CHF76 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF71.00 is trading 28.9% below its estimated GF Value™ of CHF99.84.

Key valuation signals for XSWX:ZBH:

  • Stock Based Compensation: CHF76 Mil
  • GF Value™: CHF99.84 vs. price of CHF71.00 (28.9% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
72GF Score

Get the complete analysis for XSWX:ZBH

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF71.00
Price
CHF99.84
GF Value